Roman Alekseevich Ivanov

This inventor holds 9 USPTO granted patents and 2 EPO patents. Top assignees: Joint Stock Company "Biocad", Other. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roman Alekseevich Ivanov. Retrieved from https://idiyas.com/inventor/roman-alekseevich-ivanov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

5 out of 11

Joint Stock Company "Biocad"

patents

2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12534525 - AQUEOUS PHARMACEUTICAL COMPOSITION OF AN ANTI-IL17A ANTIBODY AND USE THEREOF (2026-01-27),

2. 12410257 - Monoclonal antibody that binds specifically to GITR (2025-09-09),

3. 12297269 - Monoclonal antibodies that bind specifically to human TRBV9 (2025-05-13),

4. 12227572 - Monoclonal antibodies against the beta chain region of human TRBV9 (2025-02-18),

5. 12202906 - Monoclonal antibody that specifically binds to CD20 (2025-01-21),

6. 12173336 - PaCas9 nuclease (2024-12-24),

7. 11993647 - Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6 (2024-05-28),

8. 11453717 - Trispecific antibodies against IL-17A, IL-17F and other pro-inflammatory molecule (2022-09-27),

9. 11136408 - Anti-PD-1 antibodies, method for producing same and method for using same (2021-10-05),

Title: Roman Alekseevich Ivanov: Innovator in Biotechnology

Introduction

Roman Alekseevich Ivanov is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 9 patents to his name, Ivanov's work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents, Ivanov has developed a monoclonal antibody that binds specifically to GITR. This invention relates to antibodies or antigen-binding fragments and their applications in treating diseases associated with GITR. Additionally, he has created a monoclonal humanized antibody that specifically binds to the TRBV9 family of the human T cell receptor. This antibody has potential uses in treating conditions such as celiac disease and malignant blood diseases.

Career Highlights

Ivanov's career is marked by his innovative research and development in the field of biotechnology. His patents reflect a deep understanding of immunology and the therapeutic potential of antibodies. His work is crucial in addressing various medical challenges and improving patient outcomes.

Collaborations

Ivanov has collaborated with notable colleagues, including Dmitry Valentinovich Morozov and Timofey Aleksandrovich Nemankin. These partnerships have enhanced his research efforts and contributed to the success of his inventions.

Conclusion

Roman Alekseevich Ivanov is a distinguished inventor whose work in biotechnology is making a significant impact. His innovative patents and collaborations are advancing the field and offering new hope for medical treatments.

Profile summary based on public USPTO records.